HOME >> BIOLOGY >> NEWS
Researchers identify protein promoting vascular tumor growth

COLUMBUS, Ohio Researchers have discovered a new mechanism responsible for the growth of blood vessel tumors that can cause facial deformities in infants and young children, paving the way for an antibody-based treatment to remove cells that fuel the tumors' growth.

Blood vessel tumors require macrophages, a type of white blood cells, to develop. In studying these cells' role in tumor development, Ohio State University medical researchers determined that a protein called MCP-1 "recruits" macrophages to the vascular tumor site.

This means that therapies to eliminate the MCP-1 protein could be a key to healing or preventing the tumors and possibly others in which MCP-1 is expressed.

The results are published in the October issue of the American Journal of Physiology (Cell).

Blood vessel tumors affect up to 3 percent of all children, typically resulting in a prominent red mass on the head and neck. Up to one in four patients with hemangioendotheliomas, or HEs, the type of tumor used in these studies, die of anemia associated with the tumors.

The findings present the first evidence that MCP-1 and macrophages are needed for these tumors to grow, and the first evidence that anti-MCP-1 therapy prevents vascular tumor development in animals with intact immune systems, said Gayle Gordillo, lead author of the study, assistant professor of plastic surgery and an investigator in the Davis Heart and Lung Research Institute at Ohio State University Medical Center.

When MCP-1 recruits macrophages to the tumor site, it stimulates new blood vessel development, or angiogenesis, in endothelial cells that make up the lining of blood vessels. That proliferation can cause the tumors to grow because new vessels develop and allow blood to collect in the lesion. Gordillo, in partnership with Heart and Lung Research Institute investigators Chandan Sen and Sashwati Roy, determined MCP-1's role in recruiting macrophages by
'"/>

Contact: Emily Caldwell
caldwell.151@osu.edu
614-293-3737
Ohio State University
29-Sep-2004


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers devise potent new tools to curb ivory poaching
4. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
5. Researchers ID chlorophyll-regulating gene
6. Researchers develop fast track way to discover how cells are regulated
7. Researchers identify distinctive signature for metastatic prostate cancer
8. Researchers report new gene test for isolated cleft lip and palate
9. Researchers discover why mutant gene causes colon cancer
10. Researchers identify the genomes controlling elements
11. Researchers improve detection of diverse anthrax strains

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... ... November 08, 2019 , ... SiteSeer Technologies, creator of ... as a new client and user of SiteSeer. The boutique real estate developer of ... U.S. will use SiteSeer to supplement its own analysis of markets. , Geoffrey ...
(Date:11/6/2019)... , ... November 06, 2019 , ... ... version 2.0 today. The Genomic Search Engine now includes the ability to search ... further accelerate diagnosis of patients with genetic and rare diseases. , Patients, particularly ...
(Date:10/30/2019)... ... October 29, 2019 , ... ... for SIEMENS ATELLICA® analyzers, Order Numbers 701sa & 704sa. The kits, in a ... UTP, and UUN. , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... Bode Technology ... of Forensic Genealogy, Melinde Lutz Byrne, to the organization. Byrne’s team will strengthen ... investigative leads to law enforcement through proven genealogy and DNA analysis methods. , ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... for use in pathology research, today announced the results of analyses examining ... enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations were demonstrated ...
(Date:11/6/2019)... ... November 06, 2019 , ... LeadingBiotech ,?an ... today announces its East/West CEO conference to be held January 11-12, ... , Kicking off the week of the J.P. Morgan Healthcare Conference and other ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare , ... for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from ... 2.0 will give urologists across Europe the ability to perform targeted transrectal and ...
Breaking Biology Technology:
Cached News: